Factors Associated With Clinical Deterioration Among Patients Hospitalized on the Wards at a Tertiary Cancer Hospital.
Journal
Journal of oncology practice
ISSN: 1935-469X
Titre abrégé: J Oncol Pract
Pays: United States
ID NLM: 101261852
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
pubmed:
16
7
2019
medline:
8
8
2020
entrez:
16
7
2019
Statut:
ppublish
Résumé
Patients hospitalized outside the intensive care unit (ICU) frequently experience clinical deterioration. Little has been done to describe the landscape of clinical deterioration among inpatients with cancer. We aimed to describe the frequency of clinical deterioration among patients with cancer hospitalized on the wards at a major academic hospital and to identify independent risk factors for clinical deterioration among these patients. This was a retrospective cohort study at a 1,300-bed urban academic hospital with a 138-bed inpatient cancer center. We included consecutive admissions to the oncology wards between January 1, 2014, and June 30, 2017. We defined clinical deterioration as the composite of ward death and transfer to the ICU. We evaluated 21,219 admissions from 9,058 patients. The composite outcome occurred during 1,945 admissions (9.2%): 1,365 (6.4%) had at least one ICU transfer, and 580 (2.7%) involved ward death. Logistic regression identified several independent risk factors for clinical deterioration, including the following: age (odds ratio [OR], 1.33 per decade; 95% CI, 1.07 to 1.67), male sex (OR, 1.15; 95% CI, 1.05 to 1.33), comorbidities, illness severity (OR, 1.11; 95% CI, 1.10 to 1.13), emergency admission (OR, 1.45; 95% CI, 1.26 to 1.67), hospitalization on particular wards (OR, 1.525; 95% CI, 1.326 to 1.67), bacteremia (OR, 1.24; 95% CI, 1.01 to 1.52), fungemia (OR, 3.76; 95% CI, 1.90 to 7.41), tumor lysis syndrome (OR, 3.01; 95% CI, 2.41 to 3.76), and receipt of antimicrobials (OR, 2.04; 95% CI, 1.72 to 2.42) and transfusions (OR, 1.65; 95% CI, 1.42 to 1.92). Clinical deterioration was common; it occurred in more than 9% of admissions. Factors independently associated with deterioration included comorbidities, admission source, infections, and blood product transfusion.
Identifiants
pubmed: 31306039
doi: 10.1200/JOP.18.00765
pmc: PMC6694031
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e652-e665Subventions
Organisme : NHLBI NIH HHS
ID : T32 HL007317
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States
Références
JAMA Oncol. 2017 Apr 01;3(4):524-548
pubmed: 27918777
Crit Care Med. 2019 Feb;47(2):e120-e128
pubmed: 30335623
Am J Respir Crit Care Med. 2014 Sep 15;190(6):649-55
pubmed: 25089847
Intensive Care Med. 2004 May;30(5):965-71
pubmed: 15052383
Ann Intensive Care. 2017 Dec;7(1):62
pubmed: 28608137
N Engl J Med. 2011 May 12;364(19):1844-54
pubmed: 21561350
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
Aust Crit Care. 2018 Nov;31(6):363-368
pubmed: 29429570
PLoS One. 2016 Aug 17;11(8):e0161401
pubmed: 27532679
J Hosp Med. 2013 May;8(5):236-42
pubmed: 23440923
Ann Hematol. 2018 Jul;97(7):1271-1282
pubmed: 29704018
JAMA. 2016 Dec 27;316(24):2674-2675
pubmed: 28027358
Crit Care Med. 1999 Mar;27(3):633-8
pubmed: 10199547
Br J Anaesth. 2012 Mar;108(3):452-9
pubmed: 22298243
Crit Care. 2014 Feb 11;18(1):107
pubmed: 24517551
Oncologist. 2017 Dec;22(12):1506-1509
pubmed: 28904174
Eur J Cardiothorac Surg. 2012 Mar;41(3):598-602
pubmed: 22345181
Med Care. 2005 Nov;43(11):1073-7
pubmed: 16224299
Med Care. 2009 Jun;47(6):626-33
pubmed: 19433995
J Biomed Inform. 2016 Dec;64:10-19
pubmed: 27658885
Springerplus. 2016 Nov 29;5(1):2038
pubmed: 27995015
Crit Care Med. 2014 Apr;42(4):905-9
pubmed: 24361969
J Clin Oncol. 2013 Aug 1;31(22):2810-8
pubmed: 23752112
Cancer. 2008 Mar 1;112(5):1096-105
pubmed: 18286506
Cancer. 2018 May 1;124(9):2018-2025
pubmed: 29390174
JAMA Oncol. 2015 Dec;1(9):1303-10
pubmed: 26448610
Crit Care. 2013 Dec 30;17(6):R302
pubmed: 24377481
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Crit Care Med. 2010 Jan;38(1):9-15
pubmed: 19829101
Intensive Care Med. 2008 May;34(5):790-2
pubmed: 18214436
Leuk Lymphoma. 2013 Aug;54(8):1724-9
pubmed: 23185988
Anaesthesia. 2005 Apr;60(4):340-7
pubmed: 15766336
Intensive Care Med. 2014 Sep;40(9):1275-84
pubmed: 24972886
J Intensive Care Med. 2020 Mar;35(3):297-302
pubmed: 29262748
Crit Care Med. 2018 Sep;46(9):1402-1410
pubmed: 29939878
J Hosp Med. 2015 Sep;10(9):592-8
pubmed: 26073058
J Clin Oncol. 2005 Jul 1;23(19):4406-13
pubmed: 15994150
Crit Care Med. 2015 Jul;43(7):1439-48
pubmed: 25803653
J Oncol Pract. 2017 Oct;13(10):e821-e830
pubmed: 28763260
Intensive Care Med. 2012 Sep;38(9):1505-13
pubmed: 22592633
Crit Care Med. 2016 Feb;44(2):368-74
pubmed: 26771782
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1029-36
pubmed: 27371756
JAMA. 2017 Nov 21;318(19):1861-1862
pubmed: 28975266